Targeting CD52 provides durable depletion of circulating CAR T cells in a patient with BCMA-CAR T-cell–associated parkinsonism

Blood Immunology & Cellular Therapy · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles